Predictors of antipsychotic-induced weight gain in first-episode psychosis Conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol / Sahoo Saddichha en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - pp. 27-31 Título : Predictors of antipsychotic-induced weight gain in first-episode psychosis Conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol Tipo de documento: texto impreso Autores: Sahoo Saddichha, Autor ; Shahul Ameen, Autor ; Sayeed Akhtar, Autor Fecha de publicación: 2023 Artículo en la página: pp. 27-31 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiacepinas, Índice de masa corporal, Haloperidol, Olanzapina, Risperidona, Esquizofrenia. Resumen: Antipsychotic-induced weight gain is one of the most distressing adverse effects being observed in recent times. Most studies have been limited by several confounders. Link: ./index.php?lvl=notice_display&id=30869 [artículo] Predictors of antipsychotic-induced weight gain in first-episode psychosis Conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol [texto impreso] / Sahoo Saddichha, Autor ; Shahul Ameen, Autor ; Sayeed Akhtar, Autor . - 2023 . - pp. 27-31. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - pp. 27-31 Palabras clave: Antipsicóticos, Benzodiacepinas, Índice de masa corporal, Haloperidol, Olanzapina, Risperidona, Esquizofrenia. Resumen: Antipsychotic-induced weight gain is one of the most distressing adverse effects being observed in recent times. Most studies have been limited by several confounders. Link: ./index.php?lvl=notice_display&id=30869

---

1 (1 - 1 / 1)